We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-2.98%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$112B
AUM Growth
-$23.9B
Cap. Flow
-$21.6B
Cap. Flow %
-19.26%
Top 10 Hldgs %
10.96%
Holding
4,902
New
569
Increased
1,472
Reduced
1,734
Closed
704

Sector Composition

Rank Sector Weight
1 Technology 15.18%
2 Healthcare 9.91%
3 Consumer Discretionary 9.25%
4 Financials 6.45%
5 Industrials 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNYA icon
3576
iShares MSCI China A ETF
CNYA
$221M
$343K ﹤0.01%
+12,257
New +$342K
ACLS icon
3577
CALL
Axcelis
ACLS
$4.12B
$343K ﹤0.01%
+6,900
New +$436K
ALTL icon
3578
Pacer Lunt Large Cap Alternator ETF
ALTL
$92.8M
$343K ﹤0.01%
9,843
FATE icon
3579
Fate Therapeutics
FATE
$281M
$342K ﹤0.01%
433,192
-1,103,441
-72% -$1.35M
IEUR icon
3580
iShares Core MSCI Europe ETF
IEUR
$8.66B
$342K ﹤0.01%
+5,679
New +$334K
PSTL
3581
Postal Realty Trust
PSTL
$723M
$341K ﹤0.01%
23,914
-10,405
-30% -$140K
DFAR icon
3582
Dimensional US Real Estate ETF
DFAR
$1.82B
$341K ﹤0.01%
+14,360
New +$339K
PHR icon
3583
PUT
Phreesia
PHR
$632M
$340K ﹤0.01%
13,300
-30,000
-69% -$816K
NEU icon
3584
PUT
NewMarket
NEU
$7.17B
$340K ﹤0.01%
+600
New +$316K
ORN icon
3585
Orion Group Holdings
ORN
$514M
$339K ﹤0.01%
64,869
-16,391
-20% -$115K
XPH icon
3586
State Street SPDR S&P Pharmaceuticals ETF
XPH
$469M
$339K ﹤0.01%
7,737
-700
-8% -$30.9K
SRCE icon
3587
1st Source
SRCE
$2.07B
$339K ﹤0.01%
+5,665
New +$350K
ETR icon
3588
Entergy
ETR
$54.1B
$339K ﹤0.01%
+3,963
New +$326K
FLDDW
3589
Fold Holdings Warrant
FLDDW
$1.3M
$338K ﹤0.01%
+375,000
New +$304K
SOXQ icon
3590
Invesco PHLX Semiconductor ETF
SOXQ
$2.38B
$337K ﹤0.01%
10,021
-54,546
-84% -$2.11M
OSBC icon
3591
Old Second Bancorp
OSBC
$1.24B
$337K ﹤0.01%
+20,247
New +$362K
PVH icon
3592
CALL
PVH
PVH
$3.71B
$336K ﹤0.01%
+5,200
New +$420K
IHRT icon
3593
iHeartMedia
IHRT
$535M
$333K ﹤0.01%
201,939
+115,167
+133% +$232K
ESEA icon
3594
Euroseas
ESEA
$543M
$333K ﹤0.01%
10,851
-9,833
-48% -$273K
RGEN icon
3595
Repligen
RGEN
$7.44B
$332K ﹤0.01%
2,612
-2,447
-48% -$377K
PCYO icon
3596
Pure Cycle
PCYO
$257M
$332K ﹤0.01%
31,696
+4,478
+16% +$50.9K
AA icon
3597
Alcoa
AA
$11.7B
$329K ﹤0.01%
10,800
-33,757
-76% -$1.18M
S icon
3598
CALL
SentinelOne
S
$6.22B
$329K ﹤0.01%
18,100
-4,100
-18% -$89K
RILY icon
3599
CALL
BRC Group Holdings
RILY
$277M
$329K ﹤0.01%
85,000
+55,000
+183% +$249K
BC icon
3600
CALL
Brunswick
BC
$5.19B
$328K ﹤0.01%
+6,100
New +$382K

Similar funds

D.E. Shaw & Co's Q1 2025 Portfolio in Review

As of Q1 2025, D.E. Shaw & Co held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

D.E. Shaw & Co withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, D.E. Shaw & Co opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.

  • D.E. Shaw & Co's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
  • D.E. Shaw & Co added most to GE Vernova in Q1 2025, an estimated $686M increase.
  • D.E. Shaw & Co's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
  • D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
  • D.E. Shaw & Co's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
  • D.E. Shaw & Co opened 569 new positions and closed 704 in Q1 2025.
  • D.E. Shaw & Co's portfolio value fell 18% quarter-over-quarter to $112B.

Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.